CXCL9

CXCL9

CXCL9 詳細

Molecule Name
C-X-C motif chemokine 9
分子の別称
CMK, Humig, MIG, SCYB9, crg-10
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
C-X-C motif chemokine 9,Gamma-interferon-induced monokine,Monokine induced by interferon-gamma (HuMIG; MIG),Small-inducible cytokine B9,SCYB9,Crg-10,Humig,CMK,MIG,Monokine Induced By Gamma Interferon,Monokine Induced By Interferon-Gamma,Gamma-Interferon-Induced Monokine,Chemokine (C-X-C Motif) Ligand 9,Small-Inducible Cytokine B9,C-X-C Motif Chemokine 9,HuMIG
バックグランド
CXCL9 is a small cytokine belonging to the CXC chemokine family that is also known as monokine induced by gamma interferon (MIG). CXCL9 is a chemokine that plays a role in immune responses, it can induce chemotaxis, promote differentiation and proliferation of leukocytes, and cause tissue extravasation. CXCL9 regulates immune cell migration, differentiation and activation by binding to CXCR3 receptor, such as CTLs, NK cells, NKT cells and macrophages. CXCL9 also participates in Th1 polarization and IFN-γ response.

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
NG-641EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAPPhase 1 ClinicalAkamis Bio Ltd, University Of Oxford
Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis
詳細